Sharon Nahm
@sharonnahmMedical oncologist in Sydney, Australia. PhD candidate - Thinking and Talking about Prognosis in Advanced cancer.
Similar User
@KfOncology
@LKasherman
@JiaJennyLiu
@thelimbiconc
@AOParsonson
@janette_vardy
@HaoWenSim
@Mal_Itchins
@shalsubra
@DrChristinaTeng
@BelindaKiely
@YChenLee
@SamuelXStevens
@ausyoungoncs
@DrBenKong
Ping @DrAbhiPal @omalirp @DrChristinaTeng @DrBenKong @drprunellab @DKarikios @AOParsonson @DrLizConnolly @DrMelMoore @Mal_Itchins @AshMalalasekera @PeeySei @SandhuShahneen @TommyJohn00 - pls consider completing and sharing with colleagues! 🙏🏾
Study finds oncologists are no more likely to overestimate survival time than to underestimate it. Simple multiples of EST provide well-calibrated estimates of worst-case, typical, and best-case scenarios for survival: oxford.ly/4e9hyUQ @martinstockler
Hot off the press in @NatRevClinOncol ! Using examples from trials presented at #ASCO23, in this educational piece, I highlight how we should think about crossover in cancer clinical trials. Such education also forms a core theme of what we do @csoncol In this piece, I argue…
Fabulous to be back at Grand Rounds FTT again with Martin Stockler helping us estimate 3 survival scenarios for patients with advanced cancer. CTC.USYD.edu.au/3scenarios/ @drprunellab
😂
Good luck to all the PhD students this week, where all their family try to understand what they do and ask when they will be done.
It's not too late to register for tonight's free, online multidisciplinary conversation about ageism in cancer #COSAageism ➡️ bit.ly/cosa-ageism-fo… ⬅️ (While you're there, register for next week too!) #GeriOnc #Ageism
Such a practical and important tool to have available in the clinic - amazing work @MOGA_ORG @sharonnahm @BelindaKiely @MartinStockler
@sharonnahm discussing 3 Scenarios for Survival, a web-based tool, that assists with discussing survival expectancy with patients. 91% of patients & families found the information helpful. ctc.usyd.edu.au/3scenarios/ #NSWCancerConf22
Wouldn’t you love to know what this study showed? Fantastic work from YOGAs at @MOGA_ORG ASM 2022 @sharonnahm
Was great to see the familiar faces of old colleagues again! Thanks for inviting me to speak at the #SoOMelanoma2022 study day today.
We look forward to welcoming delegates to our #SooMelanoma2022 study day today. We are joined by expert speakers from around the world and will explore professional views and patients' perspectives.
The 28th June sees us explore Melanoma, with our professional speakers. With only a FEW DAYS LEFT to secure your place, book your ticket now and don’t miss out. You can join us LIVE or ON-DEMAND to watch back at your convenience. 💻 bit.ly/37aDS2x #SoOMelanoma2022
Join us on 28th June for our #SoOMelanoma2022 study day. Using professional expertise & patient perspectives, we look holistically at early interventions & and the current clinical trials in place. Book now: bit.ly/37waPqm
“Who’s going to teach Ben all this stuff?” I think it’s a good question. smh.com.au/education/aust…
>25% of ppl receiving ICIs had an emergency presentation and 1 in 3 were due to IRAEs. 40% had previous >G2 IRAEs and 29% required 2L immunosuppression. Excited to share real-world data from @TheChristieNHS published in the The European Journal of Cancer. authors.elsevier.com/a/1eamd3QE--RV…
Wordle 209 3/6 🟩🟩⬛⬛⬛ 🟩🟩🟩🟩⬛ 🟩🟩🟩🟩🟩 Too good not to share! #luckyguess
Don't forget to register your interest with @COSAoncology to get an Asia Pacific focused Global Oncology group going. A place for PallCare, RadOnc, MedOnc, all Oncs and Allied Health wanting to improve outcome in our region. @ausyoungoncs @Pall_Care_Aus @FacRadOncology #APROSIG
Attention @COSAoncology members: Call for expressions of interest for the formation of a new COSA Global Oncology Group. The support of 30 COSA members is required for this to be realised. #globonc #aushealth
Excited to be a part of #ACORD21 this year and eager to learn from a diverse group of faculty and participants! moga.org.au/acord-workshop
Excited to be part of the next episode of #OJC discussing the cancersurvivalrates.com website. Thanks for inviting me to discuss this great resource for people affected by cancer and their doctors.
NEW PODCAST: OJC Episode 46 is jam packed! Covering testing, burnout, Aboriginal trial participation, tuna sandwiches and a chat with @BelindaKiely on prognosis. Thanks @profevasegelov @CraigUnderhill - we miss you @HPrenen oncologynews.com.au/the-ojc-46/ #meded #oncologypodcast #OJC
The majority of patients with emergency presentations due to IO toxicity at The Christie were treated with combination immunotherapy for melanoma. More than 1/3 had previous ≥ grade 2 IO toxicity and 1/4 required second-line immunosuppression. meetinglibrary.asco.org/record/198755/… #ASCO21
Multivariable analysis of The Christie cohort of people w lung cancer and melanoma found antibiotic use independently reduces PFS and OS in patients treated with tyrosine kinase inhibitors. meetinglibrary.asco.org/record/197570/… #ASCO21
United States Trends
- 1. #UFC309 296 B posts
- 2. Jon Jones 167 B posts
- 3. Jon Jones 167 B posts
- 4. Jon Jones 167 B posts
- 5. Chandler 87,4 B posts
- 6. Oliveira 71,9 B posts
- 7. Kansas 22,8 B posts
- 8. #discorddown 6.765 posts
- 9. Bo Nickal 8.930 posts
- 10. Do Bronx 11 B posts
- 11. Arod 2.166 posts
- 12. #BYUFootball 1.386 posts
- 13. Rock Chalk 1.383 posts
- 14. Tennessee 55,4 B posts
- 15. #MissUniverse 434 B posts
- 16. Tatum 28,4 B posts
- 17. Oregon 34,4 B posts
- 18. #kufball 1.091 posts
- 19. Keith Peterson 1.349 posts
- 20. Big 12 1.781 posts
Who to follow
-
Kat Francis
@KfOncology -
Lawrence Kasherman
@LKasherman -
Jia (Jenny) Liu MD PhD
@JiaJennyLiu -
the limbic
@thelimbiconc -
Dr Andrew Parsonson
@AOParsonson -
Janette Vardy
@janette_vardy -
Hao-Wen Sim
@HaoWenSim -
Malinda Itchins
@Mal_Itchins -
Shalini Subramaniam
@shalsubra -
Christina Teng
@DrChristinaTeng -
Belinda Kiely
@BelindaKiely -
ChenLee
@YChenLee -
Sam Stevens
@SamuelXStevens -
ausyoungoncs
@ausyoungoncs -
Ben Kong
@DrBenKong
Something went wrong.
Something went wrong.